Juventas Therapeutics, Inc.
Get Full AccessDescription
- Juventas Therapeutics is a private, clinical stage biotechnology company developing novel non-viral gene therapies that activate natural processes to repair the body. Our product candidate, JVS-100, is a non-viral gene therapy that expresses stromal cell-derived factor-1, or SDF-1, a naturally occurring signaling protein that has been shown to recruit the bodys own stem cells and promote tissue repair in a broad range of disease states. Juventas therapeutic approach is based on research originating at the Cleveland Clinic. Juventas is currently enrolling a Phase 2b study in patients with advanced peripheral artery disease.
-
Headquarters:3615 Superior Avenue Suite 4403b, Cleveland, Ohio, United States
More -
Phone Number: +1 216-273-4000
-
Website: https://www.juventasinc.com
-
Employees:5
-
Revenue:$1 - 10M
-
Legal Name:Juventas Therapeutics, Inc.
-
Juventas Therapeutics, Inc.'s Social Media
- Is this data correct?
-
| NAICS Code: 325412 |
Show More
Frequently Asked Questions regarding Juventas Therapeutics, Inc.
-
Where are Juventas Therapeutics, Inc.'s Headquarters?
Juventas Therapeutics, Inc.'s Headquarters are in 3615 Superior Avenue Suite 4403b,Cleveland,Ohio,United States
-
What is Juventas Therapeutics, Inc.'s phone number?
Juventas Therapeutics, Inc.'s phone number is +1 216-273-4000
-
What is Juventas Therapeutics, Inc.'s official website?
Juventas Therapeutics, Inc.'s official website is https://www.juventasinc.com
-
What is Juventas Therapeutics, Inc.'s Revenue?
Juventas Therapeutics, Inc.'s revenue is $1 - 10M
-
What is Juventas Therapeutics, Inc.'s NAICS code?
Juventas Therapeutics, Inc.'s NAICS code is 325412
-
How many employees are working in Juventas Therapeutics, Inc.
Juventas Therapeutics, Inc. has 5 employees
-
What is Juventas Therapeutics, Inc.'s Industry?
Juventas Therapeutics, Inc. is in the industry of Biotechnology
-
Who is Juventas Therapeutics, Inc.'s Senior Vice President, Clinical Product Development?
Juventas Therapeutics, Inc.'s Senior Vice President, Clinical Product Development is Joe Pastore